Gestational Trophoblastic Neoplasia Rate and Its Related Factors in Women With a Partial Hydatidiform Mole at Tudu Hospital, Vietnam

被引:0
作者
Sr, Tuan M. Vo [1 ]
Hoang, Tuyet T. [1 ]
Tran, Hoang M. [2 ]
Nyamakope, Kimberley [3 ]
机构
[1] Univ Med & Pharm HCMC Ho Chi Minh City, Obstet & Gynaecol OB GYN, Ho Chi Minh, Vietnam
[2] Univ Med & Pharm HCMC Ho Chi Minh City, Diagnost Radiol, Ho Chi Minh City, Vietnam
[3] Somerset NHS Fdn Trust, Fdn Sch, Somerset, England
关键词
female patient; partial hydatidiform mole; gestational trophoblastic neoplasia; choriocarcinoma; chemoprophylaxis; CLINICAL-FEATURES; RISK-FACTORS; DISEASE;
D O I
10.7759/cureus.67495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Minimal studies have been carried out on a partial hydatidiform mole (PHM) in Vietnam, so the treatment outcomes for patients with PHM are unknown. This study aimed to determine the occurrence rate of gestational trophoblastic neoplasia (GTN) and its related factors in women with PHM at Tu Du Hospital, Vietnam. Materials and methods This retrospective cohort study included 370 women with PHM diagnosed through a histopathological assessment following termination of pregnancy at Tu Du Hospital from January 2020 to December 2021. Survival analysis was used for GTN cumulative rate estimation and the Cox regression model for determining GTN-related factors. Results After a 1-year follow-up, 21 patients were found to have GTN, exhibiting a rate of 5.7% (95% confidence interval (CI): 3.5- 8.4). GTN occurred 4.67 +/- 2.23 weeks following curettage with peaks at weeks 3-6. No cases of GTN were recorded eight weeks following termination by curettage. After multivariate analysis, the GTN rate was higher in patients with a history of miscarriage/termination (hazard ratio (HR)=2.84; 95% CI: 1.057.69). Conclusion The rate of GTN in PHM patients was 5.7%. Patients who had a history of miscarriage or termination were 2.84 times more likely to develop GTN than patients who did not.
引用
收藏
页数:7
相关论文
共 17 条
  • [1] Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors
    Bakhtiyari, Mahmood
    Mirzamoradi, Masoumeh
    Kimyaiee, Parichehr
    Aghaie, Abbas
    Mansournia, Mohammd Ali
    Ashrafi-vand, Sepideh
    Sarfjoo, Fatemeh Sadat
    [J]. FERTILITY AND STERILITY, 2015, 104 (03) : 649 - 654
  • [2] BALTAZAR JC, 1976, B WORLD HEALTH ORGAN, V54, P523
  • [3] Molar Pregnancy
    Berkowitz, Ross S.
    Goldstein, Donald P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (16) : 1639 - 1645
  • [4] Dieu Hang LT, 2013, Vietnam Journal of Obstetrics & Gynecology, V11, P49
  • [5] Feltmate CM, 2006, J REPROD MED, V51, P902
  • [6] Current Management of Gestational Trophoblastic Neoplasia
    Goldstein, Donald Peter
    Berkowitz, Ross S.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (01) : 111 - +
  • [7] Joneborg U, 2014, J REPROD MED, V59, P51
  • [8] Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles
    Lavie, I
    Rao, GG
    Castrillon, DH
    Miller, DS
    Schorge, JO
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (05) : 1362 - 1364
  • [9] RISK-FACTORS FOR GESTATIONAL TROPHOBLASTIC NEOPLASIA
    MESSERLI, ML
    LILIENFELD, AM
    PARMLEY, T
    WOODRUFF, JD
    ROSENSHEIN, NB
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 153 (03) : 294 - 300
  • [10] Gestational Trophoblastic Disease: An Overview
    Monchek, Ruth
    Wiedaseck, Susan
    [J]. JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2012, 57 (03) : 255 - 259